NFKB1 and prostate cancer: In another study, Acetyl-beta boswellic acid and BA stopped the activity of I-κB kinase in chemotherapeutic androgen-independent PC-3 prostate cancer cells in vitro and in vivo, inhibiting activated NF-κB signaling, reducing proliferation and leading to cell death [17].